Genetic and Genomic Markers of Anti-TNF Treatment Response in Rheumatoid Arthritis
- 16 June 2015
- journal article
- review article
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 9 (6) , 499-512
Abstract
Despite the success of anti-TNF drugs in the treatment of rheumatoid arthritis, a significant rate of nonresponse remains. Current clinical factors confer little power for predicting response and, in current practice, an unsatisfactory ‘trial and error’ approach governs therapeutic decisions. Candidate gene and unbiased genome-wide investigations have sought to identify genetic biomarkers that predict who will respond to anti-TNF drugs before the drug is administered. To date, few studies have yielded robust associations; herein, we discuss currently identified associations and the issues that need to be addressed in future investigations including insufficient power and an inadequate measure of disease activity. The potential for alternative predictors of anti-TNF therapy response from transcriptomic and epigenetic data will also be explored.Keywords
Funding Information
- Arthritis Research UK (ref 20385)
- the National Institute for Health Research Manchester Musculoskeletal Biomedical Research Unit
This publication has 108 references indexed in Scilit:
- Tobacco Smoking Leads to Extensive Genome-Wide Changes in DNA MethylationPLOS ONE, 2013
- Development of a Multi-Biomarker Disease Activity Test for Rheumatoid ArthritisPLOS ONE, 2013
- Metabolic Profiling Predicts Response to Anti–Tumor Necrosis Factor α Therapy in Patients With Rheumatoid ArthritisArthritis & Rheumatism, 2013
- Personal Omics Profiling Reveals Dynamic Molecular and Medical PhenotypesCell, 2012
- Replication of association of the PTPRC gene with response to anti–tumor necrosis factor therapy in a large UK cohortArthritis & Rheumatism, 2011
- Reduction of long‐term disability in inflammatory polyarthritis by early and persistent suppression of joint inflammation: Results from the Norfolk Arthritis RegisterArthritis Care & Research, 2011
- Tobacco-Smoking-Related Differential DNA Methylation: 27K Discovery and ReplicationThe American Journal of Human Genetics, 2011
- Genome‐wide association study of genetic predictors of anti–tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven lociArthritis & Rheumatism, 2010
- Intra-individual Change Over Time in DNA Methylation With Familial ClusteringJAMA, 2008
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis & Rheumatism, 1995